Realizing the Transformative Value of Harvard Innovation 

Harvard University’s research enterprise is a wellspring of innovation with the potential to improve lives, transform industries, and create tremendous social and economic value. Facilitating the transfer of cutting-edge Harvard innovation from the lab to the global public sphere is the mission of OTD. 

Serving as an unbiased agent, we are responsible for managing Harvard’s intellectual property assets for the public good. Our global focus helps ensure innovations benefit people throughout the world, regardless of their economic circumstances. We fulfill this mission by:

Harvard faculty discuss the important role OTD plays in connecting Academia and Industry.


Want to know more about OTD?

Contact Us

Upholding fundamental values

As stewards of Harvard’s intellectual property, we are guided by a clear set of values:

  • Maximize the impact of new knowledge resulting from University research and discovery
  • Protect faculty and student rights by preserving the principle of academic freedom
  • Adhere to the highest ethical standards in all dealings and relationships
  • Serve as a trusted and creative negotiator of fair, mutually beneficial agreements
  • Achieve a high level of service and responsiveness to the faculty

Connecting with commercial partners 

OTD has a history of forging mutually beneficial relationships with industry and investors who share our mission of creating value by serving the public good. Our entrepreneurial approach and diverse expertise enables us to create choice partnerships, helping our partners connect with promising technologies, quickly and efficiently.

In partnership with Harvard's Office of Technology Development, we were able to achieve our goals and forge a deal in both an efficient and effective manner. Working in concert with a team of experienced, knowledgeable and results-oriented professionals was a pleasure. Together with their open-mindedness to adapt, this made all the difference in achieving a real 'win-win' outcome.

Joshua Boger, Ph.D.

Founder, Vertex Pharmaceuticals Incorporated


Want to learn more?

Connect with Us